Nutex Health (NUTX) Competitors

Nutex Health (NASDAQ:NUTX) and DLocal (NASDAQ:DLO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Which has more risk and volatility, NUTX or DLO?

Nutex Health has a beta of -0.1, meaning that its stock price is 110% less volatile than the S&P 500. Comparatively, DLocal has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Does the media prefer NUTX or DLO?

In the previous week, DLocal had 6 more articles in the media than Nutex Health. MarketBeat recorded 17 mentions for DLocal and 11 mentions for Nutex Health. DLocal's average media sentiment score of 0.75 beat Nutex Health's score of 0.64 indicating that DLocal is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutex Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DLocal	5 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in NUTX or DLO?

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 90.1% of DLocal shares are held by institutional investors. 38.5% of Nutex Health shares are held by company insiders. Comparatively, 45.4% of DLocal shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts prefer NUTX or DLO?

Nutex Health currently has a consensus target price of $262.50, suggesting a potential upside of 55.33%. DLocal has a consensus target price of $11.56, suggesting a potential upside of 0.89%. Given Nutex Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Nutex Health is more favorable than DLocal.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
DLocal	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Does the MarketBeat Community believe in NUTX or DLO?

DLocal received 10 more outperform votes than Nutex Health when rated by MarketBeat users. However, 100.00% of users gave Nutex Health an outperform vote while only 32.43% of users gave DLocal an outperform vote.

Company	Underperform	Outperform
Nutex Health	Outperform Votes 14 100.00%	Underperform Votes No Votes
DLocal	Outperform Votes 24 32.43%	Underperform Votes 50 67.57%

Which has stronger valuation and earnings, NUTX or DLO?

DLocal has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than DLocal, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$624.28M	1.51	-$45.79M	$11.89	14.21
DLocal	$778.30M	4.20	$148.96M	$0.49	23.39

Is NUTX or DLO more profitable?

DLocal has a net margin of 16.35% compared to Nutex Health's net margin of -14.09%. DLocal's return on equity of 32.59% beat Nutex Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutex Health	-14.09%	-51.27%	-9.89%
DLocal	16.35%	32.59%	12.95%

Summary

DLocal beats Nutex Health on 13 of the 17 factors compared between the two stocks.